Donor double-negative Treg promote allogeneic mixed chimerism and tolerance

European Journal of Immunology

Volumn 37, Issue 12, 2007, Pages 3455-3466

  He, Kathy M ^a   Ma, Yuexia ^a   Wang, Shuang ^a,b   Min, Wei Ping ^a,b,c   Zhong, Robert ^a,b,c   Jevnikar, Anthony ^a,b,c   Zhang, Zhu Xu ^a,b,c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c Lawson Institute of Health Research   (Canada)

Author keywords

Bone marrow; Chimerism; Double negative Treg; NK cells

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS LIGAND; PERFORIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADOPTIVE TRANSFER; ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL THERAPY; CHIMERA; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD8; BONE MARROW TRANSPLANTATION; FAS LIGAND PROTEIN; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; H-2 ANTIGENS; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; MALE; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, REGULATORY; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 37549007140     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737408     Document Type: Article

References (70)

1. Sykes, M., Mixed chimerism and transplant tolerance. Immunity 2001. 14: 417-424.
2. Tomita, Y., Khan, A. and Sykes, M., Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J. Immunol. 1994. 153: 1087-1098.
3. Manilay, J. O., Pearson, D. A., Sergio, J. J., Swenson, K. G. and Sykes, M., Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 1998. 66: 96-102.
4. Kitchens, W. H., Uehara, S., Chase, C. M., Colvin, R. B., Russell, P. S. and Madsen, J. C., The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 2006. 81: 811-817.
5. Uehara, S., Chase, C. M., Kitchens, W. H., Rose, H. S., Colvin, R. B., Russell, P. S. and Madsen, J. C., NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allografts. J. Immunol. 2005. 175: 3424-3430.
6. Le Moine, A. and Goldman, M., Non-classical pathways of cell-mediated allograft rejection: New challenges for tolerance induction? Am J. Transplant. 2003. 3: 101-106.
7. Vilches, C. and Parham, P., Do NK-cell receptors and alloreactivity affect solid organ transplantation? Transpl. Immunol. 2006. 17: 27-30.
8. Murphy, W. J., Koh, C. Y., Raziuddin, A., Bennett, M. and Longo, D. L., Immunobiology of natural killer cells and bone marrow transplantation: Merging of basic and preclinical studies. Immunol. Rev. 2001. 181: 279-289.
9. Murphy, W. J. and Longo, D. L., The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation. Immunol. Rev. 1997. 157: 167-176.
10. Cudkowicz, G. and Bennett, M., Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. J. Exp. Med. 1971. 134: 1513-1528.
11. Ljunggren, H. G. and Karre, K., In search of the 'missing self: MHC molecules and NK cell recognition. Immunol. Today 1990. 11: 237-244.
12. Murphy, W. J., Kumar, V. and Bennett, M., Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J. Exp. Med. 1987. 165: 1212-1217.
13. Yokoyama, W. M. and Seaman W. E., The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex. Annu. Rev. Immunol. 1993. 11: 613-635.
14. Suzue, K., Reinherz, E. L. and Kayasu, S., Critical role of NK but not NKT cells in acute rejection of parental bone marrow cells in F1 hybrid mice. Eur. J. Immunol. 2001. 31: 3147-3152.
15. Kean, L. S., Hamby, K., Koehn, B., Lee, E., Coley, S., Stempora, L., Adams, A. B. et al., NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. Am. J. Transplant. 2006. 6: 292-304.
16. Westerhuis, G., Maas, W. G., Willemze, R., Toes, R. E. and Fibbe, W. E., Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood 2005. 106: 2215-2220.
17. Cho, S. G., Shuto, Y., Soda, Y., Nakazaki, Y., Izawa, K., Uchimaru, K., Takahashi, S. et al., Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation. Exp. Hematol. 2004. 32: 1246-1254.
18. Zhao, Y., Ohdan, H., Manilay, J. O. and Sykes, M., NK cell tolerance in mixed allogeneic chimeras. J. Immunol. 2003. 170: 5398-5405.
19. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 2005. 6: 345-352.
20. + regulatory T cells. Proc. Natl. Acad. Sci. USA 2006. 103: 5460-5465.
21. + T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 2005. 105: 1828-1836.
22. Zhang, Z. X., Yang, L., Young, K. J., DuTemple, B. and Zhang, L., Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med. 2000. 6: 782-789.
23. Ford, M. S., Young, K. J., Zhang, Z., Ohashi, P. S. and Zhang, L., The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J. Exp. Med. 2002. 196: 261-267.
24. Young, K. J., Yang, L., Phillips, M. J. and Zhang, L., Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 2002. 100: 3408-3414.
25. Zhang, Z. X., Stanford, W. L. and Zhang, L., Ly-6A is critical for the function of double negative regulatory T cells. Eur. J. Immunol. 2002. 32: 1584-1592.
26. Zhang, Z. X., Ma, Y. X., Wang, H., Arp, J., Jaing, J., Huang, X., Madrenas, J. and Zhong, R., Double negative T cells lyse autologous lymphocytes using a perforin/granzyme-dependent, Fas-FasL-independent pathway. J. Immunol. 2006. 177: 6920-6929.
27. Chen, W., Ford, M. S., Young, K. J. and Zhang, L., Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice. Transplant. Proc. 2003. 35: 2479-2480.
28. Zhang, D., Yang, W., Degauque, N., Tian, Y., Mikita, A. and Zheng, X. X., New differentiation pathway for double-negative regulatory T-cells that regulates the magnitude of immune responses. Blood 2007. 109: 4071-4079.
29. Priatel, J. J., Utting, O. and Teh, H. S., TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells. J. Immunol. 2001. 167: 6188-6194.
30. - T cells with regulatory functions dominates the mouse female genital tract. J. Immunol. 2003. 170: 1659-1666.
31. - double negative regulatory T cells. Blood 2005. 105: 2828-2838.
32. Young, K. J., DuTemple, B., Zhang, Z., Levy, G. and Zhang, L., CD4(-)CD8(-) regulatory T cells implicated in preventing graft-versus-host and promoting graft-versus-leukemia responses. Transplant. Proc. 2001. 33: 1762-1763.
33. Young, K. J., DuTemple, B., Phillips, M. J. and Zhang, L., Inhibition of graft-versus-host disease by double-negative regulatory T cells. J. Immunol. 2003. 171: 134-141.
34. Xu, H., Chilton, P. M., Huang, Y., Schanie, C. L. and Ildstad, S. T., Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J. Immunol. 2004. 172: 1463-1471.
35. Kanamoto, A. and Maki, T., Chimeric donor cells play an active role in both induction and maintenance phases of transplantation tolerance induced by mixed chimerism. J. Immunol. 2004. 172: 1444-1448.
36. Elwood, E. T., Larsen, C. P., Maurer, D. H., Routenberg, K L., Neylan, J. F., Whelchel, J. D., O'Brien, D. P. and Pearson, T. C., Microchimerism and rejection in clinical transplantation. Lancet 1997. 349: 1358-1360.
37. Hisanaga, M., Hundrieser, J., Boker, K., Uthoff, K., Raddatz, G., Wahlers, T., Wonigeit, K. et al., Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation 1996. 61: 40-45.
38. Umemura, A., Morita, H., Li, X. C., Tahan, S., Monaco, A. P. and Maki, T., Dissociation of hemopoietic chimerism and allograft tolerance after allogeneic bone marrow transplantation. J. Immunol. 2001. 167: 3043-3048.
39. Ildstad, S. T., Wren, S. M., Bluestone, J. A., Barbieri, S. A., Stephany, D. and Sachs, D. H., Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs. -host disease in mixed allogeneic chimeras (B10 + B10.D2 - B10). J. Immunol. 1986. 136: 28-33.
40. Ildstad, S. T., Wren, S. M., Bluestone, J. A., Barbieri, J. A. and Sachs, D. H., Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J. Exp. Med. 1985. 162: 231-244.
41. Wekerle, T. and Sykes, M., Mixed chimerism and transplantation tolerance. Annu. Rev. Med. 2001. 52: 353-370.
42. Thomas, J. M., Carver, F. M., Foil, M. B., Hall, W. R., Adams, C., Fahrenbruch, G. B. and Thomas, F. T., Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation 1983. 36: 104-106.
43. Kimikawa, M., Sachs, D. H., Colvin, R. B., Bartholomew, A., Kawai, T. and Cosimi, A. B., Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation 1997. 64: 709-716.
44. Kawai, T., Wee, S. L., Bazin, H., Latinne, D., Phelan, J., Boskovic, S., Ko, D. S. et al., Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates. Transplantation 2000. 70: 368-374.
45. Ruedi, E., Sykes, M., Ildstad, S. T., Chester, C. H., Althage, A., Hengartner, H., Sachs, D. H. and Zinkernagel, R. M., Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2 - P1) irradiation chimeras. Cell. Immunol. 1989. 121: 185-195.
46. Colson, Y. L., Li, H., Boggs, S. S., Patrene, K. D., Johnson, P. C. and Ildstad, S. T., Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach. J. Immunol. 1996. 157: 2820-2829.
47. Sykes, M., Szot, G. L., Swenson, K. A. and Pearson, D. A., Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat. Med. 1997. 3: 783-787.
48. Colson, Y. L., Lange, J., Fowler, K. and Ildstad, S. T., Mechanism for cotolerance in nonlethally conditioned mixed chimeras: Negative selection of the Vbeta T-cell receptor repertoire by both host and donor bone marrow-derived cells. Blood 1996. 88: 4601-4610.
49. Spitzer, T. R., Delmonico, F., Tolkoff-Rubin, N., McAfee, S., Sackstein, R., Saidman, S., Colby, C. et al., Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999. 68: 480-484.
50. Ricordi, C., Karatzas, T., Nery, J., Webb, M., Selvaggi, G., Fernandez, L., Khan, F. A. et al., 1997. High-dose donor bone marrow infusions to enhance allograft survival: The effect of timing. Transplantation 1997. 63: 7-11.
51. Rao, A. S., Fontes, P., Zeevi, A., Rugeles, M., Shapiro, R. Jordan, M., Corry, R. et al., Enhancement of donor cell chimerism in whole organ allograft recipients by adjuvant bone marrow transplantation. Transplant. Proc. 1995. 27: 3387-3388.
52. Rao, A. S., Fontes, P., Zeevi, A., Trucco, M., Dodson, F. S., Rybka, W. B., Shapiro, R. et al., Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant. Proc. 1995. 27: 210-212.
53. Zeevi, A., Pavlick, M., Banas, R., Bentlejewski, C., Spichty, K., Rao, A. S., Foutes, P. et al., Three years of follow-up of bone marrow-augmented organ transplant recipients: The impact on donor-specific immune modulation. Transplant. Proc. 1997. 29: 1205-1206.
54. Corry, R. J., Chakrabarti, P. K., Shapiro, R., Rao, A. S., Dvorchik, L., Jordan, M. L, Scantlebury, V. P. et al., Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann. Surg. 1999. 230: 372-379.
55. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft- versus-host disease after bone marrow transplantation. Nat. Med. 2003. 9: 1144-1150.
56. + regulatory T cells protects from lethal acute GVHD. Blood 2005. 105: 2220-2226.
57. + regulatory T cells during acute graft-versus-host disease. Blood 2005. 106: 3300-3307.
58. Cohen, J. L., Trenado, A., Vasey, D., Klatzmann, D. and Salomon, B. L., CD4(+)CD25(+) immunoregulatory T cells: New therapeutics for graft-versus-host disease. J. Exp. Med., 196: 401-406.
59. von Boehmer, H., Mechanisms of suppression by suppressor T cells. Nat. Immunol. 2005. 6: 338-344.
60. James, M. J., Belaramani, L., Prodromidou, K., Datta, A., Nourshargh, S., Lombardt G., Dyson, J. et al., Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism. Blood 2003. 102: 2173-2179.
61. Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L. et al., Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 2003. 4: 1206-1212.
62. + T cells lyse antigen-presenting B cells by Fas-Fas ligand interaction in an epitope-specific manner. J. Immunol. 2003. 171: 4604-4612.
63. Grossman, W. J., Verbsky, J. W., Tollefsen, B. L., Kemper, C., Atkinson, J. P. and Ley, T. J., Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004. 104: 2840-2848.
64. + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J. Exp. Med. 2005. 202: 1075-1085.
65. Bellone, G., Aste-Amezaga, M., Trinchieri, G. and Rodeck, U., Regulation of NK cell functions by TGF-beta 1. J. Immunol. 1995. 155: 1066-1073.
66. + double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production. J. Immunol. 2003. 171: 2421-2426.
67. Koh, C. Y., Ortaldo, J. R., Blazar, B. R., Bennett, M. and Murphy, W. J., NK-cell purging of leukemia: Superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade. Blood 2003. 102: 4067-4075.
68. Matzinger, P., The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 1991. 145: 185-192.
69. Hoves, S., Krause, S. W., Scholmerich, J. and Fleck, M., The JAM-assay: Optimized conditions to determine death-receptor-mediated apoptosis. Methods 2003. 31: 127-134.
70. 51Cr-release assay to assess the cytotoxicity of dendritic cells on hematopoietic tumor cells. Immunol. Invest. 2003. 32: 219-227.